Cervical Pathology Following HPV Vaccination in Greece: A 10-year HeCPA Observational Cohort Study

In Vivo. 2020 May-Jun;34(3):1445-1449. doi: 10.21873/invivo.11927.

Abstract

Background: In Greece the population-level impact of HPV vaccination is unknown due to lack of official registries. This study presents in a pragmatic frame the comparison of cervical pathology data between HPV-vaccinated and unvaccinated women referred for colposcopy.

Patients and methods: This is an observational prospective cohort study performed in 7 academic Obstetrics and Gynaecology Departments across Greece between 2009-2019. Cases were women that had completed HPV vaccination before coitarche and were referred for colposcopy due to abnormal cytology. For each vaccinated woman an unvaccinated matched control was selected.

Results: A total of 849 women who had been vaccinated before coitarche and 849 unvaccinated controls were recruited. The combination of cytological, colposcopic and molecular findings necessitated treatment in only a single case among vaccinated (0.1%) and in 8.4% among unvaccinated.

Conclusion: HPV vaccination at a proper age can markedly reduce development of severe cervical precancers and consequently the need for treatment, as well as their long-term related obstetrical morbidity.

Keywords: HPV; vaccination; vaccine.

MeSH terms

  • Adult
  • Cervix Uteri / pathology*
  • Cervix Uteri / virology
  • Cohort Studies
  • Colposcopy
  • Cytodiagnosis
  • Female
  • Greece / epidemiology
  • Humans
  • Papillomaviridae / immunology
  • Papillomavirus Infections / complications*
  • Papillomavirus Infections / epidemiology
  • Papillomavirus Infections / prevention & control*
  • Papillomavirus Vaccines / administration & dosage
  • Papillomavirus Vaccines / immunology*
  • Public Health Surveillance
  • Uterine Cervical Neoplasms / epidemiology*
  • Uterine Cervical Neoplasms / etiology
  • Uterine Cervical Neoplasms / pathology
  • Vaccination

Substances

  • Papillomavirus Vaccines